Table 1.
Characteristics | CST1 expression | p value | ||||
---|---|---|---|---|---|---|
Total (n = 75) | Low (n = 49), n (%) | High (n = 26), n (%) | ||||
Age (years) | ||||||
>50 | 31 | 19 (38.78) | 12 (46.15) | .625 | ||
≤50 | 44 | 30 (61.22) | 14 (53.85) | |||
Gender | ||||||
Male | 60 | 40 (81.63) | 20 (76.92) | .763 | ||
Female | 15 | 9 (18.37) | 6 (23.08) | |||
HBV infection | ||||||
Yes | 58 | 35 (71.43) | 23 (88.46) | .147 | ||
No | 17 | 14 (28.57) | 3 (11.54) | |||
Liver cirrhosis | ||||||
Yes | 68 | 43 (87.76) | 25 (96.15) | .410 | ||
No | 7 | 6 (12.24) | 1 (3.85) | |||
Serum AFP (ng/ml) | ||||||
>20 | 52 | 37 (75.51) | 15 (57.69) | .124 | ||
≤20 | 23 | 12 (24.49) | 11 (42.31) | |||
Tumor diameter (cm) | ||||||
>5 | 25 | 11 (55.10) | 14 (26.92) | .010 | ||
≤5 | 50 | 38 (44.90) | 12 (73.08) | |||
Lymph node metastasis | ||||||
Yes | 26 | 13 (26.53) | 13 (50.00) | .073 | ||
No | 49 | 36 (73.47) | 13 (50.00) | |||
TNM stage | ||||||
I‐II | 31 | 25 (51.02) | 6 (23.08) | .027 | ||
III‐IV | 44 | 24 (48.98) | 20 (76.92) |
Abbreviations: AFP: α‐fetoprotein; HBV: hepatitis B virus.